Medknow Publications and Staff Society of Seth GS Medical College and KEM Hospital, Mumbai, India
Abstract
Background: Aspergillus is a common cause of invasive mycosis,
especially in immunocompromised or immunosuppressed individuals. Aims:
To study the incidence of invasive pulmonary aspergillosis and evaluate
the predisposing factors and clinico-pathological manifestations.
Settings and Design: Retrospective analysis of autopsy material from a
tertiary care hospital. Material and Methods: All autopsies performed
over a 12-year period were reviewed and cases with invasive
aspergillosis were analysed with respect to their clinical
presentation, predisposing factors, gross and histological features,
complications and causes of death. Results: Among a total of 20475
autopsies performed in 12 years, 39 patients (0.19 %) had invasive
pulmonary aspergillosis. There were 28 males and 11 females. Their ages
ranged from five months to 67 years. Dyspnoea, fever, cough with
mucopurulent expectoration, chest pain and haemoptysis were commonly
encountered symptoms. Forty-one per cent of the patients had no
respiratory symptoms. Fungal aetiology was not entertained clinically
in any of the patients. The major underlying conditions were prolonged
antibiotic therapy, steroid therapy, and renal transplantation, often
associated with underlying lung diseases. Pneumonia, abscesses,
vascular thrombosis and infarction were common findings at autopsy.
Antecedent tuberculosis, mucormycosis, Pneumocystis carinii pneumonia
and Cytomegalovirus infection were also present. In most cases, death
was related to extensive pulmonary involvement or fungal dissemination.
Conclusion: A diagnosis of invasive pulmonary aspergillosis should
always be borne in mind whenever one is dealing with recalcitrant lung
infections even with subtle immunosuppression. Radiological
investigations and serologic markers can be utilised for confirmation
and prompt therapy